Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.2B | 1.2B | 1.2B |
Cost of revenue | 100.3M | 94.9M | 101.1M | 101.0M |
Gross profit | 1.1B | 1.1B | 1.1B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.3B | 941.7M | 866.2M | 990.0M |
Operating income | -204.3M | 120.2M | 246.0M | 99.1M |
Non operating interest income | ||||
Income | 13.4M | 9.6M | 10.4M | 8.7M |
Expense | 202.2M | 245.6M | 211.1M | 204.7M |
Other income expense | — | — | — | — |
Pretax income | 561.1M | -261.2M | 34.6M | -24.4M |
Tax provision | 150.0M | 24.9M | 38.9M | 28.3M |
Net income | 411.1M | -286.1M | -4.3M | -52.6M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 18.4B | 18.4B | 18.4B | 18.4B |
Diluted average shares | 18.4B | 18.4B | 18.4B | 18.4B |
EBITDA | -124.9M | -15.5M | 245.6M | 285.7M |
Net income from continuing op. | 561.1M | -261.2M | 34.6M | -24.4M |
Minority interests | -5.4M | -7.0M | -919K | 134.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |